Resources Access for Preclinical Integrated Drug Development (RAPIDD) Program (X01 Clinical Trial Not Allowed)

Go to Funding Search

Key Information

Due Date: January 17, 2025


Agency: U.S. Department of Health and Human Services (HHS)


Source: Federal


Funding Category:

Health & Human Services

Funding Amount: $581,371


Funding Type: Grant


Match Required: No


Status: Posted


Contact Info: OERWebmaster03@od.nih.gov
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.

Overview

The grant in discussion is the Resources Access for Preclinical Integrated Drug Development (RAPIDD) Program, which does not accommodate clinical trials (X01 Clinical Trial Not Allowed).

This grant is designed to offer preclinical services that function to bridge gaps in product development. The purpose of this Funding Opportunity Announcement (FOA) is to support and streamline the process of developing potential treatments specifically targeted towards HIV and related co-infections such as Hepatitis B, Hepatitis C, and Tuberculosis.

This grant primarily serves to benefit academic and private institutions actively involved in the discovery and development of such therapies. The objective is to offer assistance to these entities to advance their research and realize the potential of promising HIV-related therapeutics swiftly and successfully.

Show More

Key Dates

Open Date: May 27, 2022


Application Due Date: January 17, 2025


Estimated Award Date: Not Specified

Additional Details

Eligible Activities

  • Research and Development

Eligible Applicants

  • State governments
  • County governments
  • City, village or township governments
  • Special district governments
  • Independent school districts
  • Public and State controlled institutions of higher education
  • Private institutions of higher education
  • Small businesses

Search MI Funding Hub

NOTE: Site search does not include grant search. See Find Funding page for grant searching.